Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Thomas Geramita

Physician Assistant, Surgical Morristown, NJ Physician Assistant

NPI 1629212428 CMS profile 10776315

160 Hanover Avenue, Morristown, NJ 07962

Open in the dashboard

General payments

$9,554

326 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Geramita of Morristown, NJ is reported in the CMS Open Payments database as having received $9,554 across 326 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,314 44
2024 General $1,657 52
2023 General $2,708 86
2022 General $2,553 101
2021 General $1,323 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Geramita
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Thomas Geramita were reported at $1,314. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Thomas Geramita Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,323 $111 $36–$285 $132
2022 $2,553 $126 $44–$350 $149
2023 $2,708 $137 $47–$355 $160
2024 $1,657 $146 $49–$384 $164
2025 $1,314 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $3,239 121 payments
  2. Boston Scientific Corporation $2,754 56 payments
  3. Abbott Laboratories $982 35 payments
  4. Janssen Pharmaceuticals, Inc $507 19 payments
  5. Pfizer Inc. $465 21 payments
  6. Amgen Inc. $448 20 payments
  7. AstraZeneca Pharmaceuticals LP $400 19 payments
  8. Novo Nordisk Inc $187 10 payments
  9. Novartis Pharmaceuticals Corporation $100 6 payments
  10. Cardiva Medical, Inc. $93 4 payments
  11. Other $378 15 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,554 326 payments
Products named General payments · program years 2021–2025
  1. COBALT DR MRI SURESCAN $1,280 48 payments
  2. LUX-Dx Insertable Cardiac Monitor $1,041 20 payments
  3. LATITUDE Communicator Power Supply $915 20 payments
  4. Micra $839 26 payments
  5. XARELTO $507 19 payments
  6. ELIQUIS $465 21 payments
  7. Repatha $448 20 payments
  8. AZURE XT DR MRI SURESCAN $232 10 payments
  9. FARXIGA $202 10 payments
  10. ZOOM Wireless Transmitter $201 3 payments
  11. Other $3,580 140 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

326 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record